Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Mutations and response to epidermal growth factor receptor inhibitors.

Laurent-Puig P, Lievre A, Blons H.

Clin Cancer Res. 2009 Feb 15;15(4):1133-9. doi: 10.1158/1078-0432.CCR-08-0905. Review.

PMID:
19228718
[PubMed - indexed for MEDLINE]
Free Article
2.

KRAS mutational testing in the selection of patients for EGFR-targeted therapies.

Garcia J, Riely GJ, Nafa K, Ladanyi M.

Semin Diagn Pathol. 2008 Nov;25(4):288-94. Review.

PMID:
19013894
[PubMed - indexed for MEDLINE]
3.

Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities.

Mishani E, Abourbeh G, Eiblmaier M, Anderson CJ.

Curr Pharm Des. 2008;14(28):2983-98. Review.

PMID:
18991714
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model.

Gleysteen JP, Newman JR, Chhieng D, Frost A, Zinn KR, Rosenthal EL.

Head Neck. 2008 Jun;30(6):782-9. doi: 10.1002/hed.20782.

PMID:
18228526
[PubMed - indexed for MEDLINE]
5.

Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts.

Withrow KP, Newman JR, Skipper JB, Gleysteen JP, Magnuson JS, Zinn K, Rosenthal EL.

Technol Cancer Res Treat. 2008 Feb;7(1):61-6.

PMID:
18198926
[PubMed - indexed for MEDLINE]
6.

In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies.

Barrett T, Koyama Y, Hama Y, Ravizzini G, Shin IS, Jang BS, Paik CH, Urano Y, Choyke PL, Kobayashi H.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6639-48. Epub 2007 Nov 2.

PMID:
17982120
[PubMed - indexed for MEDLINE]
Free Article
7.

Use of monoclonal anti-EGFR antibody in the radioimmunotherapy of malignant gliomas in the context of EGFR expression in grade III and IV tumors.

Wygoda Z, Kula D, Bierzyńska-Macyszyn G, Larysz D, Jarzab M, Właszczuk P, Bazowski P, Wojtacha M, Rudnik A, Stepień T, Kaspera W, Etmańska A, Składowski K, Tarnawski R, Kokocińska D, Jarzab B.

Hybridoma (Larchmt). 2006 Jun;25(3):125-32.

PMID:
16796458
[PubMed - indexed for MEDLINE]
8.

Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapy.

Pnwar P, Iznaga-Escobar N, Mishra P, Srivastava V, Sharma RK, Chandra R, Mishra AK.

Cancer Biol Ther. 2005 Aug;4(8):854-60.

PMID:
16082184
[PubMed - indexed for MEDLINE]
Free Article
9.

Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.

Ke S, Wen X, Gurfinkel M, Charnsangavej C, Wallace S, Sevick-Muraca EM, Li C.

Cancer Res. 2003 Nov 15;63(22):7870-5.

PMID:
14633715
[PubMed - indexed for MEDLINE]
Free Article
10.

Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo.

Soukos NS, Hamblin MR, Keel S, Fabian RL, Deutsch TF, Hasan T.

Cancer Res. 2001 Jun 1;61(11):4490-6.

PMID:
11389080
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.

Reilly RM, Kiarash R, Sandhu J, Lee YW, Cameron RG, Hendler A, Vallis K, Gariépy J.

J Nucl Med. 2000 May;41(5):903-11.

PMID:
10809207
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk